FITC Anti-Human CD326 Antibody[ 9C4]

The FITC Anti-Human CD326 Antibody [9C4] is a highly specific and reliable tool designed for the detection and analysis of CD326 expression in human samples. This antibody is conjugated with fluorescein isothiocyanate (FITC), a widely used fluorochrome known for its exceptional brightness and stability.

CD326, also known as EpCAM (Epithelial Cell Adhesion Molecule), is a transmembrane glycoprotein that plays a crucial role in cell adhesion and signaling. It is expressed on the surface of various epithelial tissues and is involved in the maintenance of tissue integrity and differentiation. CD326 has been identified as a potential biomarker for various cancers, including breast, colon, and lung cancer, making it an important target for diagnostic and therapeutic applications.

The FITC Anti-Human CD326 Antibody [9C4] has been extensively validated for its specificity and sensitivity in flow cytometry and immunofluorescence assays. It exhibits minimal cross-reactivity with other cell surface markers, ensuring accurate and reliable results. The FITC conjugation allows for direct visualization of CD326-positive cells using fluorescence microscopy or flow cytometry, enabling researchers to study the distribution and expression levels of CD326 in various cell populations.

This antibody is supplied as a liquid formulation in a convenient size of 100 µg, ensuring ample quantity for multiple experiments. It is provided in a ready-to-use format, eliminating the need for additional conjugation steps or optimization. The FITC Anti-Human CD326 Antibody [9C4] is compatible with a wide range of sample types, including cell lines, primary cells, and tissue sections, facilitating its application in diverse research areas.

In summary, the FITC Anti-Human CD326 Antibody [9C4] is a highly specific and reliable tool for the detection and analysis of CD326 expression. Its exceptional performance in various assays, along with its convenient formulation, makes it an ideal choice for researchers studying CD326 in the context of cancer biology, tissue development, and other related fields.